What is he best known for?
The fields of study he is best known for:
- Enzyme
- Biochemistry
- Internal medicine
The scientist’s investigation covers issues in Biochemistry, Sphingomyelin, Internal medicine, Ceramide and Endocrinology.
His Biochemistry study frequently intersects with other fields, such as Chromatography.
His research in Sphingomyelin intersects with topics in Intestinal mucosa and Alkaline phosphatase.
His Internal medicine research includes elements of Gastroenterology and Linoleic acid.
The various areas that Åke Nilsson examines in his Ceramide study include ENPP7, Phosphatidylcholine and Receptor, Lipid signaling.
His Endocrinology research incorporates elements of Potassium, Arachidonic acid, Transacylation and Magnesium.
His most cited work include:
- The presence of sphingomyelin- and ceramide-cleaving enzymes in the small intestinal tract (181 citations)
- Sources of eicosanoid precursor fatty acid pools in tissues (155 citations)
- Oral budesonide versus prednisolone in patients with active extensive and left-sided ulcerative colitis (154 citations)
What are the main themes of his work throughout his whole career to date?
Åke Nilsson spends much of his time researching Biochemistry, Internal medicine, Endocrinology, Sphingomyelin and Chylomicron.
Biochemistry is frequently linked to Molecular biology in his study.
His Internal medicine study frequently draws connections between adjacent fields such as Gastroenterology.
His study looks at the intersection of Endocrinology and topics like Magnesium with Peripheral blood mononuclear cell and Potassium.
His studies in Sphingomyelin integrate themes in fields like Sphingolipid, Ceramide, Intestinal mucosa and Alkaline phosphatase.
His research integrates issues of Platelet and Chylomicron remnant in his study of Chylomicron.
He most often published in these fields:
- Biochemistry (44.55%)
- Internal medicine (32.73%)
- Endocrinology (25.91%)
What were the highlights of his more recent work (between 2001-2019)?
- Biochemistry (44.55%)
- Sphingomyelin (20.00%)
- Internal medicine (32.73%)
In recent papers he was focusing on the following fields of study:
His primary areas of study are Biochemistry, Sphingomyelin, Internal medicine, Endocrinology and Molecular biology.
Åke Nilsson frequently studies issues relating to Intestinal mucosa and Biochemistry.
Åke Nilsson has included themes like Ceramide and Enzyme in his Sphingomyelin study.
His studies link Potassium with Internal medicine.
His Postprandial, Pancreas and Urine study, which is part of a larger body of work in Endocrinology, is frequently linked to Orlistat, bridging the gap between disciplines.
His work deals with themes such as Carcinogenesis and HT29 Cells, which intersect with Molecular biology.
Between 2001 and 2019, his most popular works were:
- Boswellic acids trigger apoptosis via a pathway dependent on caspase-8 activation but independent on Fas/Fas ligand interaction in colon cancer HT-29 cells (144 citations)
- Metabolism of sphingolipids in the gut and its relation to inflammation and cancer development. (122 citations)
- Identification of human intestinal alkaline sphingomyelinase as a novel ecto-enzyme related to the nucleotide phosphodiesterase family (120 citations)
In his most recent research, the most cited papers focused on:
- Enzyme
- Internal medicine
- Biochemistry
His main research concerns Biochemistry, Internal medicine, Molecular biology, Sphingomyelin and Sphingolipid.
His Biochemistry study often links to related topics such as Intestinal mucosa.
Internal medicine and Endocrinology are frequently intertwined in his study.
His Molecular biology study integrates concerns from other disciplines, such as HT29 Cells and Alkaline phosphatase.
His Sphingomyelin course of study focuses on Ceramide and Digestion and Phosphodiesterase.
His Sphingolipid research is multidisciplinary, incorporating perspectives in Sphingosine and Ceramidase.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
